FDA Approved: LUMAKRAS — Supplemental Application (Amgen Inc)

View source ↗

Summary

FDA approved Amgen's supplemental application for LUMAKRAS (sotorasib), updating the labeling to reflect the information approved in the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• LUMAKRAS (sotorasib)

Snippet

SUPPL AP for LUMAKRAS (SOTORASIB)